25 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
6
Synthesis and bioactivity ofß-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Universiteit Gent
8
Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR).
University of Strasburg
14
Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.
Heinrich Heine Universit£T
11
Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents.
University of Groningen
3
The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
George Washington University
24
IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters.
Lehrstuhl FÜR Biochemie
24
DXR inhibition by potent mono- and disubstituted fosmidomycin analogues.
Uppsala University
43
AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase.
Philipps University
4
Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.
University of Strasburg
19
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes.
Baylor College of Medicine
1
Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis.
Uppsala University
6
Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
Oregon State University
6
Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
Uppsala University
16
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies.
Baylor College of Medicine
4
Expanding the Chemical Space of Reverse Fosmidomycin Analogs.
Heinrich Heine University Dusseldorf
9
Inhibition of DXR in the MEP pathway with lipophilic N-alkoxyaryl FR900098 analogs.
George Washington University
8
Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.
Birla Institute of Technology and Science-Pilani
7
Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
Ghent University
9
Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.
Ghent University
15
Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.
Heinrich Heine University D£Sseldorf
6
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
University of Illinois At Urbana - Champaign
37
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
University of Pennsylvania
22
Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics.
Mayo Foundation
21
The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
Gsk